Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 31% ± 9% | |
astrocyte | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 32% ± 15% |
Insufficient scRNA-seq data for expression of RFNG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2624.95 | 1445 / 1445 | 100% | 28.24 | 183 / 183 |
liver | 100% | 4114.69 | 226 / 226 | 100% | 48.35 | 406 / 406 |
ovary | 100% | 4147.56 | 180 / 180 | 100% | 42.08 | 430 / 430 |
pancreas | 100% | 2378.67 | 328 / 328 | 100% | 31.50 | 178 / 178 |
thymus | 100% | 2981.72 | 653 / 653 | 100% | 37.60 | 605 / 605 |
uterus | 100% | 3302.25 | 170 / 170 | 100% | 38.60 | 459 / 459 |
brain | 100% | 2179.76 | 2635 / 2642 | 100% | 36.84 | 705 / 705 |
prostate | 100% | 3745.85 | 245 / 245 | 100% | 49.20 | 500 / 502 |
skin | 100% | 2623.24 | 1808 / 1809 | 100% | 41.35 | 470 / 472 |
kidney | 100% | 2655.45 | 89 / 89 | 99% | 32.59 | 895 / 901 |
stomach | 100% | 2326.33 | 359 / 359 | 99% | 27.36 | 284 / 286 |
intestine | 100% | 2637.11 | 966 / 966 | 99% | 27.89 | 523 / 527 |
adrenal gland | 100% | 2638.78 | 258 / 258 | 99% | 31.42 | 228 / 230 |
breast | 100% | 2818.61 | 459 / 459 | 99% | 31.57 | 1107 / 1118 |
lung | 100% | 2328.89 | 577 / 578 | 99% | 30.97 | 1143 / 1155 |
bladder | 100% | 2875.48 | 21 / 21 | 99% | 41.14 | 497 / 504 |
adipose | 100% | 2806.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 41.41 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.92 | 29 / 29 |
spleen | 100% | 2424.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.34 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.05 | 1 / 1 |
muscle | 100% | 2174.48 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2547.86 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1397.46 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1362.23 | 922 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0030154 | Biological process | cell differentiation |
GO_0007399 | Biological process | nervous system development |
GO_0007389 | Biological process | pattern specification process |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0033829 | Molecular function | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | RFNG |
Protein name | RFNG protein Beta-1,3-N-acetylglucosaminyltransferase radical fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) |
Synonyms | hCG_1820367 |
Description | FUNCTION: Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Modulates NOTCH1 activity by modifying O-fucose residues at specific EGF-like domains resulting in enhancement of NOTCH1 activation by DLL1 and JAG1. May be involved in limb formation and in neurogenesis. . |
Accessions | B4DXP6 J3QLN0 ENST00000310496.9 F5H3H7 A6H8Z0 ENST00000578356.1 Q9Y644 ENST00000429557.7 |